Nearly one million people have received an experimental coronavirus vaccine developed by Sinopharm as part of an emergency use program approved by Beijing, the Chinese pharmaceutical giant’s president said.
No serious side effects have been reported from vaccine recipients so far, Sinopharm said on Wednesday in an article on the social media platform WeChat, referring to President Liu Jingzhen.
“In an emergency, we have now used it on nearly a million people. We have not received any reports of serious side effects, and only a few have some mild symptoms,” Liu said.
Liu said the vaccine was given to Chinese construction workers, diplomats and students who have gone to more than 150 countries around the world during the pandemic – and none of them have reported an infection.
He said on November 6 that there were 56,000 people who had received emergency vaccinations and then traveled abroad.
“For example, a transnational corporation has 99 employees in one of its overseas offices, 81 of whom were vaccinated. And later an outbreak broke out in the office, 10 of the 18 people who were not vaccinated became infected, and none of them , who were vaccinated were infected, “he said.
He said Sinopharm had individually conducted Phase 3 clinical trials with nearly 60,000 people in 10 countries – including the UAE, Bahrain, Egypt, Jordan, Peru and Argentina. CNN has not seen the results of these trials yet.
Sinopharm has two vaccine candidates. It is unclear which vaccine Liu was referring to.
Beijing has been approving companies for urgent vaccinations using experimental drugs for several months. In June, the Chinese company CanSino Biologics announced that it had received special permission to administer its experimental vaccine to the People’s Liberation Army.
Since July, Chinese drug manufacturers have administered experimental vaccines to people working in “high-risk” occupations under the emergency use program, allowing vaccine candidates to be used to a limited extent before their safety and efficacy are fully proven in clinical trials. .
Experimental coronavirus vaccines have even reportedly been offered to the public in parts of China, prompting some citizens across the country to grab a dose.
This comes after Pfizer announced the results of its Phase 3 coronavirus vaccine trials on Wednesday, which it said were 95% effective in preventing infections – even in older adults – and caused no serious safety concerns. A day earlier, Moderna announced that its coronavirus vaccine was 94.5% effective.
Pfizer is expected to apply to the U.S. Food and Drug Administration for emergency use of its vaccine Friday.
Dr. Anthony Fauci, the leading US expert in infectious diseases, said the Pfizer and Moderna vaccines had shown extraordinary efficacy.
“It’s extraordinary,” Fauci said. “It’s almost on par with what we see with measles (vaccine), which is 98% effective.”